2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents. [PDF]
Herrstedt J +8 more
europepmc +1 more source
Cannabis Use by Veterans and Potential Interactions With Antineoplastic Agents: Analysis and Literature Review. [PDF]
Todorova T +6 more
europepmc +1 more source
Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents. [PDF]
Wang Y, Hu Y, Wang T, Che G, Li L.
europepmc +1 more source
A microfluidic tumor platform integrates pharmacokinetic flow control, vascular‐like barriers, and 3D tumor spheroids to emulate in vivo drug exposure. The system reproduces dynamic concentration–time profiles and enables size‐dependent nanoparticle transport and efficacy evaluation, providing a predictive framework for assessing nanomedicine ...
Su Jeong Kang +5 more
wiley +1 more source
Educational technologies for the prevention and management of extravasation of antineoplastic agents: an integrative review. [PDF]
Barbosa RFM +5 more
europepmc +1 more source
Hybrid Molecules Containing Naphthoquinone and Quinolinedione Scaffolds as Antineoplastic Agents. [PDF]
Mancini I, Vigna J, Sighel D, Defant A.
europepmc +1 more source
Single‐cell, spatial, molecular, and pathology analyses identify a CDH3‐associated malignant epithelial state in thymic epithelial tumors. This state links stem‐like and EMT programs to M2 macrophage–rich immunosuppressive niches, genomic instability, poor survival, and drug vulnerability.
Yuntao Feng +13 more
wiley +1 more source
Pulmonary toxicity from novel antineoplastic agents
Background: The pulmonary side-effects induced by novel antineoplastic agents have not been well characterized. Methods: To further investigate this topic, relevant English and non-English language studies were identified through Medline.
Bamias, A +3 more
core
Substantial Increase in the Costs of Antineoplastic Agents in the USA from 2010 to 2021. [PDF]
Althemery AU.
europepmc +1 more source
Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents. [PDF]
Eroglu I +9 more
europepmc +1 more source

